[ad_1]
Remedy in the United States no more expensive.
FRANKFURT (dpa). Following President Donald Trump's harsh criticism of high drug prices in the United States, German drug companies are now making concessions. They follow a series of heavyweights in the industry that refrain from price hikes in America so as not to provoke Trump.
The pharmaceutical and chemical company based in Darmstadt Merck also responded. "We currently do not expect any price increases in the United States for the remainder of 2018," said Merck. But you make price decisions "independently". In addition, the pharmaceutical giant Bayer Trump pressure after: He signed an agreement, the prices of all prescription drugs by the end of the year to increase, said the Group. US Secretary of Health Alex Azar was personally informed.
Trump has repeatedly criticized the high cost of the American health care system as one of the most inefficient in the world. Overly expensive prescriptions and patented medicines bother him. Recently, a large number of pharmaceutical giants, such as Roche, Novartis and Pfizer, have waived price increases in the United States. The American company Merck & Co has even announced lower prices.
Analysts see a precautionary measure in the fast and closed actions of companies. "They want to get out of Trump's fire line," says Ulrich Huwald, an badyst at private bank Mr M. Warburg. The high price of drugs is a political issue: "In autumn, there are mid-term elections for which Trump needs success." Many ads are very gently worded. "No one has announced that they will have to give up price increases in the United States forever," says Huwald. However, German manufacturers generate only small amounts of their sales in the United States.
Source link
